Rapport Therapeutics, Common Stock Price on October 31, 2024
| RAPP Stock | 24.00 1.16 5.08% |
If you're considering investing in Rapport Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rapport Therapeutics, stands at 24.00, as last reported on the 3rd of December, with the highest price reaching 24.17 and the lowest price hitting 22.88 during the day. Rapport Therapeutics, appears to be not too volatile, given 3 months investment horizon. Rapport Therapeutics, maintains Sharpe Ratio (i.e., Efficiency) of 0.0623, which implies the firm had a 0.0623% return per unit of risk over the last 3 months. We have found thirty technical indicators for Rapport Therapeutics,, which you can use to evaluate the volatility of the company. Please evaluate Rapport Therapeutics,'s Coefficient Of Variation of 1247.87, semi deviation of 4.57, and Risk Adjusted Performance of 0.0698 to confirm if our risk estimates are consistent with your expectations.
As of 12/03/2024, Total Stockholder Equity is likely to drop to about 88.2 M. In addition to that, Common Stock Shares Outstanding is likely to drop to about 110.5 M. At this time, Rapport Therapeutics,'s Price Book Value Ratio is relatively stable compared to the past year. As of 12/03/2024, Price To Book Ratio is likely to grow to 34.79, while Price To Operating Cash Flows Ratio is likely to drop (132.06). Rapport Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Rapport |
Sharpe Ratio = 0.0623
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RAPP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.26 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Rapport Therapeutics, is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rapport Therapeutics, by adding it to a well-diversified portfolio.
Price Book 2.2626 | Book Value 9.21 | Enterprise Value 427.9 M | Shares Float 14.9 M | Shares Outstanding 36.6 M |
Rapport Therapeutics, Main Headline on 31st of October 2024
Rapport Therapeutics Stock Price Down 10.5 percent Heres Wha... by thelincolnianonline.com
Rapport Therapeutics shares were down 10.5 percent during trading on Thursday . The company traded as low as 24.03 and last traded at 24.03. Approximately 36,385 shares were traded during trading, a decline of 78 percent from the average daily volume of 166,587 shares. The stock had previously closed at 26.84. Rapport
Rapport Therapeutics, Valuation on October 31, 2024
It is possible to determine the worth of Rapport Therapeutics, on a given historical date. On October 31, 2024 Rapport was worth 26.96 at the beginning of the trading date compared to the closed value of 24.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rapport Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Rapport Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rapport Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rapport Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 25.40 | 27.21 | 25.40 | 26.84 | 65,691 | |
10/31/2024 | 26.96 | 27.48 | 23.98 | 24.53 | 61,772 |
| 25.62 | 25.62 | 24.38 | 24.62 | 30,858 |
| Backtest Rapport Therapeutics, | | | Rapport Therapeutics, History | | | Rapport Therapeutics, Valuation | Previous | Next |
Rapport Therapeutics, Trading Date Momentum on October 31, 2024
| On November 01 2024 Rapport Therapeutics, Common was traded for 24.62 at the closing time. The top price for the day was 25.62 and the lowest listed price was 24.38 . The trading volume for the day was 30.9 K. The trading history from November 1, 2024 was a factor to the next trading day price gain. The trading delta at closing time against the next closing price was 0.37% . The trading delta at closing time against the current closing price is 10.03% . |
Rapport Therapeutics, Fundamentals Correlations and Trends
By evaluating Rapport Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rapport Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rapport financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rapport Therapeutics, Stock history
Rapport Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rapport is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rapport Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rapport Therapeutics, stock prices may prove useful in developing a viable investing in Rapport Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 164.4 M | 110.5 M |
Rapport Therapeutics, Quarterly Net Working Capital |
|
Rapport Therapeutics, Stock Technical Analysis
Rapport Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rapport Therapeutics, Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Rapport Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rapport Therapeutics, December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Rapport Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rapport Therapeutics, shares will generate the highest return on investment. By undertsting and applying Rapport Therapeutics, stock market strength indicators, traders can identify Rapport Therapeutics, Common entry and exit signals to maximize returns
Rapport Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rapport Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Rapport Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rapport to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0698 | |||
| Jensen Alpha | 0.1083 | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0598 | |||
| Treynor Ratio | 0.1535 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Rapport Stock Analysis
When running Rapport Therapeutics,'s price analysis, check to measure Rapport Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapport Therapeutics, is operating at the current time. Most of Rapport Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Rapport Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapport Therapeutics,'s price. Additionally, you may evaluate how the addition of Rapport Therapeutics, to your portfolios can decrease your overall portfolio volatility.